The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

HDFC Securities downgrades Eris to Add from Buy, as the strong run-up in the stock price factors in near-term triggers.

A Wegovy pen is placed against a bright concept background in this image shared by GoodRx Health; the product photo is ...

The global injectable drug delivery market is experiencing a significant transformation, poised to reach a staggering USD 113 ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

Chronic diseases often occur together. Diabetes can damage blood vessels, affecting the heart and kidneys. Managing blood ...

Cash position of €7.1 million as of June 30, 2025 US$10 million milestone payment from partner Tonghua Dongbao and 2024 Research Tax Credit of €2.8 million received in July 2025 Current ...